SIMMUNOME AI
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy
SIMMUNOME AI
Social Links:
Industry:
Artificial Intelligence Biotechnology Genetics Health Care
Founded:
2016-01-01
Address:
Montreal, Quebec, Canada
Country:
Canada
Website Url:
http://www.simmunome.com
Total Employee:
1+
Status:
Active
Contact:
514-518-6292
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Nginx Sitelinks Search Box Euro
Similar Organizations
Current Employees Featured
Founder
Investors List
NEXT Canada
NEXT Canada investment in Pre Seed Round - Simmunome AI
Next AI
Next AI investment in Pre Seed Round - Simmunome AI
Official Site Inspections
http://www.simmunome.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Simmunome AI"
HOME — Simmunome Inc.
Simmunome delivered a comprehensive, systems-level analysis that went beyond what we could have achieved internally, predicting key interactors, comparing our target to known ALS …See details»
Simmunome Inc. - LinkedIn
Simmunome Inc. Biotechnology Research Montréal, Quebec 1,234 followers Move your pipeline forward, with confidence.See details»
Simmunome AI - Crunchbase Company Profile
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and …See details»
Simmunome Inc. | Canada Corporation Directory
Simmunome Inc. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 211-825 Boulevard Rene-Levesque Est Montreal QC H2L 0A1 Canada.See details»
Simmunome 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Simmunome. Use the PitchBook Platform to explore the full profile.See details»
Simmunome Inc. - Creative Destruction Lab
Simmunome builds AI-driven computational disease models for use in clinical R&D. The venture focuses on accurately replicating biological processes to simulate clinical trial outcomes without the need for a client to step into a lab. …See details»
Simmunome Inc. - The Org
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases …See details»
Simmunome - Overview, News & Similar companies | ZoomInfo.com
Simmunome Inc. provides a generative AI platform that combines mechanistic modeling and machine learning to simulate drug targets' efficacy and safety, aimed at enhancing …See details»
Contact — Simmunome Inc.
Contact SimmunomeMeet us and visit our poster at ESMO in Berlin, October 17-21, 2025.See details»
MDSS - Simmunome
Simmunome's no-code SaaS platform utilizes AI-driven disease simulations to tackle high failure rates and costs in drug development. Unlike traditional AI methods that focus solely on drug …See details»
Simmunome Inc | Montreal, QC, Canada Startup
Find investment information and connect with Simmunome Inc, a Montreal, QC, Canada based Biotechnology startup.See details»
Simmunome Inc. Overview | SignalHire Company Profile
Organization Website simmunome.com Simmunome Inc. industries Biotech Headquarters Location Montréal, Quebec, CA Simmunome Inc. Employees Size 1-10 employees Founded …See details»
Simmunome — Behind the Deal. An artificial intelligence-based
Mar 7, 2023 Simmunome Co-founders — Armstrong Murira and Nardin Nakhla (from left to right) Today, we are thrilled to announce our investment in Simmunome — an artificial intelligence …See details»
Partners — Simmunome Inc.
Please tell us a little more about your organization. The Neuro-CERVO Alliance has partnered with Montreal-based AI company Simmunome to understand neurological disease …See details»
Simmunome - Osler, Hoskin & Harcourt LLP
Simmunome is an artificial intelligence company that focuses on predicting the result of clinical trials. Osler, Hoskin & Harcourt LLP advised with a team consisting of Shahir Guindi, Calvin …See details»
Simmunome - GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.See details»
Simmunome Closes Pre-Seed Funding Round
Sep 18, 2023 MONTREAL, CANADA, April 11 — Montreal-based startup Simmunome has raised $2 million in pre-seed funding to increase the efficiency of clinical trials using artificial …See details»
HOME (Copy) — Simmunome Inc.
Simmunome delivered a comprehensive, systems-level analysis that went beyond what we could have achieved internally, predicting key interactors, comparing our target to known ALS …See details»
Simmunome Selected for Inaugural Canadian Cohort of Merck …
Jun 30, 2025 MONTREAL, JUNE 20, 2025 - Simmunome Inc. is proud to announce its selection as one of seven startups invited to join the first-ever Canadian cohort of the Merck Digital …See details»
Génome Québec Funding for Simmunome — Simmunome Inc.
Feb 28, 2025 By combining multi-omic data to create comprehensive models of disease, Simmunome simulates biological processes to identify novel drug targets and predict and …See details»